Gabelli Funds’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$312K Sell
5,300
-3,000
-36% -$183K ﹤0.01% 1123
2026
Q2
$472K Buy
+8,300
New +$368K ﹤0.01% 1071

Other funds holding TVTX

Gabelli Funds's TVTX Position: Q3 2026 in Review

Gabelli Funds reduced its Travere Therapeutics (TVTX) stake by 36% in Q3 2026, selling an estimated $183K and leaving 5,300 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #1123.

Gabelli Funds first reported a position in TVTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $472K in Q2 2026. 345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.

  • Gabelli Funds held 5,300 shares of Travere Therapeutics worth $312K as of Q3 2026.
  • Gabelli Funds sold 3,000 Travere Therapeutics shares in Q3 2026, an estimated $183K.
  • Travere Therapeutics made up ﹤0.01% of Gabelli Funds's portfolio in Q3 2026, its #1123 holding.
  • Gabelli Funds first reported a position in Travere Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Gabelli Funds's Travere Therapeutics position peaked at $472K in Q2 2026.
  • 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.

Based on Gabelli Funds's 13F filing for Q3 2026, filed 12 Nov 2026.